Highlights of Nursing Role in Oncology & Hematology - Chapter 3
06:00PM - 07:30 PM GMT (+4:00)
Join us for an enriching session that aims to enhance our collective understanding and proficiency in navigating the complexities of HER-2 MBC treatment, immunotherapy side effects, and the latest developments in COVID-19 long-acting antibody combinations
20:00
-
20:05
Opening
Khaled Al Qawasmeh
20:05
-
20:25
Enhancing Care: 2nd Line Treatments for HR+/HER2- Metastatic Breast Cancer
Emad Anwar
20:25
-
20:45
What the patients' needs to know
Lina Wahba
20:45
-
20:55
Discussion
20:55
-
21:00
Summary & Closing